IRF5 is a Specific Marker of Inflammatory Macrophages in Vivo

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2014 Jan 24

PMID 24453413

Citations 71

Authors

Miriam Weiss

Katrina Blazek

Adam J Byrne

Dany P Perocheau

Irina A Udalova

Affiliations

Soon will be listed here.

Abstract

Macrophages are an integral part of the innate immune system and key players in pathogen clearance and tissue remodelling. Both functions are accomplished by a pivotal network of different macrophage subtypes, including proinflammatory M1 and anti-inflammatory M2 macrophages. Previously, our laboratory identified the transcription factor interferon regulatory factor 5 (IRF5) as the master regulator of the M1 macrophage polarisation. IRF5 was found to be highly expressed in human M1 compared to M2 macrophages. Furthermore, IRF5 dictates the expression of proinflammatory genes such as IL12b and IL23a whilst repressing anti-inflammatory genes like IL10. Here we show that murine bone marrow derived macrophages differentiated in vitro with GM-CSF are also characterised by high levels of IRF5 mRNA and protein and express proinflammatory cytokines upon LPS stimulation. These macrophages display characteristic expression of M1-marker MHC II but lack the M2-marker CD206. Significantly, we develop intracellular staining of IRF5- expressing macrophages and utilise it to recapitulate the in vitro results in an in vivo model of antigen-induced arthritis, emphasising their physiological relevance. Thus, we establish the species-invariant role of IRF5 in controlling the inflammatory macrophage phenotype both in vitro and in in vivo.

Citing Articles

EBV-Induced LINC00944: A Driver of Oral Cancer Progression and Influencer of Macrophage Differentiation.

Srisathaporn S, Ekalaksananan T, Heawchaiyaphum C, Aromseree S, Maranon D, Altina N Cancers (Basel). 2025; 17(3).

PMID: 39941858 PMC: 11815735. DOI: 10.3390/cancers17030491.

Metal-based smart nanosystems in cancer immunotherapy.

Luo Y, He X, Du Q, Xu L, Xu J, Wang J Exploration (Beijing). 2024; 4(6):20230134.

PMID: 39713201 PMC: 11655314. DOI: 10.1002/EXP.20230134.

Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome.

Debeuf N, Deckers J, Lameire S, Bosteels C, Hammad H, Lambrecht B Front Immunol. 2024; 15:1439789.

PMID: 39439800 PMC: 11493702. DOI: 10.3389/fimmu.2024.1439789.

Repeated birth injuries lead to long-term pelvic floor muscle dysfunction in the preclinical rat model.

Duran P, Zelus E, Burnett L, Christman K, Alperin M Am J Obstet Gynecol. 2024; 232(2):198.e1-198.e23.

PMID: 39191364 PMC: 11757040. DOI: 10.1016/j.ajog.2024.08.036.

The Role of Interferon Regulatory Factors in Liver Diseases.

Zeng C, Zhu X, Li H, Huang Z, Chen M Int J Mol Sci. 2024; 25(13).

PMID: 38999981 PMC: 11241258. DOI: 10.3390/ijms25136874.

References

Wang C, Rose-Zerilli M, Koppelman G, Sandling J, Holloway J, Postma D . Evidence of association between interferon regulatory factor 5 gene polymorphisms and asthma. Gene. 2012; 504(2):220-5. DOI: 10.1016/j.gene.2012.05.021. View

Davies L, Jenkins S, Allen J, Taylor P . Tissue-resident macrophages. Nat Immunol. 2013; 14(10):986-95. PMC: 4045180. DOI: 10.1038/ni.2705. View

Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N . IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011; 12(3):231-8. DOI: 10.1038/ni.1990. View

Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T . Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 2005; 434(7030):243-9. DOI: 10.1038/nature03308. View

Smeets T, Kraan M, Galjaard S, Youssef P, Smith M, Tak P . Analysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RA. Ann Rheum Dis. 2001; 60(6):561-5. PMC: 1753677. DOI: 10.1136/ard.60.6.561. View

Verreck F, de Boer T, Langenberg D, van der Zanden L, Ottenhoff T . Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol. 2005; 79(2):285-93. DOI: 10.1189/jlb.0105015. View

Gathungu G, Zhang C, Zhang W, Cho J . A two-marker haplotype in the IRF5 gene is associated with inflammatory bowel disease in a North American cohort. Genes Immun. 2012; 13(4):351-5. PMC: 3809990. DOI: 10.1038/gene.2011.90. View

Rescigno M, Citterio S, Thery C, Rittig M, Medaglini D, Pozzi G . Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A. 1998; 95(9):5229-34. PMC: 20243. DOI: 10.1073/pnas.95.9.5229. View

Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

10.

Stahl E, Raychaudhuri S, Remmers E, Xie G, Eyre S, Thomson B . Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6):508-14. PMC: 4243840. DOI: 10.1038/ng.582. View

11.

MacMicking J, Xie Q, Nathan C . Nitric oxide and macrophage function. Annu Rev Immunol. 1997; 15:323-50. DOI: 10.1146/annurev.immunol.15.1.323. View

12.

Davies L, Rosas M, Jenkins S, Liao C, Scurr M, Brombacher F . Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat Commun. 2013; 4:1886. PMC: 3842019. DOI: 10.1038/ncomms2877. View

13.

Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E . An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet. 2007; 16(24):3008-16. DOI: 10.1093/hmg/ddm259. View

14.

Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W . Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A. 2010; 107(33):14751-6. PMC: 2930428. DOI: 10.1073/pnas.1003852107. View

15.

Stone R, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P . Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum. 2011; 64(3):788-98. PMC: 3288585. DOI: 10.1002/art.33395. View

16.

Barnes B, Moore P, Pitha P . Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem. 2001; 276(26):23382-90. DOI: 10.1074/jbc.M101216200. View

17.

Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S . Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992; 176(6):1693-702. PMC: 2119469. DOI: 10.1084/jem.176.6.1693. View

18.

Draijer C, Robbe P, Boorsma C, Hylkema M, Melgert B . Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediators Inflamm. 2013; 2013:632049. PMC: 3600196. DOI: 10.1155/2013/632049. View

19.

Mosser D, Edwards J . Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8(12):958-69. PMC: 2724991. DOI: 10.1038/nri2448. View

20.

Gordon S . Alternative activation of macrophages. Nat Rev Immunol. 2003; 3(1):23-35. DOI: 10.1038/nri978. View